537 related articles for article (PubMed ID: 16126300)
1. Economic evaluation of HIV screening in pregnant women attending antenatal clinics in India.
Kumar M; Birch S; Maturana A; Gafni A
Health Policy; 2006 Jul; 77(2):233-43. PubMed ID: 16126300
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness estimates for antenatal HIV testing in the Netherlands.
Rozenbaum MH; Verweel G; Folkerts DK; Dronkers F; van den Hoek JA; Hartwig NG; de Groot R; Postma MJ
Int J STD AIDS; 2008 Oct; 19(10):668-75. PubMed ID: 18824618
[TBL] [Abstract][Full Text] [Related]
3. Would universal antenatal screening for HIV infection be cost-effective in a setting of very low prevalence? Modelling the data for Australia.
Graves N; Walker DG; McDonald AM; Kaldor JM; Ziegler JB
J Infect Dis; 2004 Jul; 190(1):166-74. PubMed ID: 15195257
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of interventions to reduce vertical HIV transmission from pregnant women who have not received prenatal care.
Mrus JM; Tsevat J
Med Decis Making; 2004; 24(1):30-9. PubMed ID: 15005952
[TBL] [Abstract][Full Text] [Related]
5. Preventing perinatal transmission of HIV--costs and effectiveness of a recommended intervention.
Gorsky RD; Farnham PG; Straus WL; Caldwell B; Holtgrave DR; Simonds RJ; Rogers MF; Guinan ME
Public Health Rep; 1996; 111(4):335-41. PubMed ID: 8711101
[TBL] [Abstract][Full Text] [Related]
6. Routine hepatitis C virus screening in pregnancy: a cost-effectiveness analysis.
Plunkett BA; Grobman WA
Am J Obstet Gynecol; 2005 Apr; 192(4):1153-61. PubMed ID: 15846195
[TBL] [Abstract][Full Text] [Related]
7. Routine prenatal screening for HIV in a low-prevalence setting.
Patrick DM; Money DM; Forbes J; Dobson SR; Rekart ML; Cook DA; Middleton PJ; Burdge DR
CMAJ; 1998 Oct; 159(8):942-7. PubMed ID: 9834719
[TBL] [Abstract][Full Text] [Related]
8. Universal antenatal human immunodeficiency virus (HIV) testing programme is cost-effective despite a low HIV prevalence in Hong Kong.
Lee PM; Wong KH
Hong Kong Med J; 2007 Jun; 13(3):199-207. PubMed ID: 17548908
[TBL] [Abstract][Full Text] [Related]
9. Economic consequences of HIV/AIDS in India.
Pandav CS; Anand K; Shamanna BR; Chowdhury S; Nath LM
Natl Med J India; 1997; 10(1):27-30. PubMed ID: 9069706
[TBL] [Abstract][Full Text] [Related]
10. [Pharmaco-economic evaluation of mandatory HIV-screening in pregnancy; a cost-efficacy analysis in Amsterdam].
Postma MJ; van den Hoek JA; Beck EJ; Heeg B; Jager JC; Coutinho RA
Ned Tijdschr Geneeskd; 2000 Apr; 144(16):749-54. PubMed ID: 10812443
[TBL] [Abstract][Full Text] [Related]
11. Voluntary screening program for HIV in pregnancy. Cost effectiveness.
Rivera-Alsina ME; Rivera CC; Rollene N; Kirby RS; Ayres A; McNamara M
J Reprod Med; 2001 Mar; 46(3):243-8. PubMed ID: 11304866
[TBL] [Abstract][Full Text] [Related]
12. Antenatal syphilis screening in sub-Saharan Africa: lessons learned from Tanzania.
Watson-Jones D; Oliff M; Terris-Prestholt F; Changalucha J; Gumodoka B; Mayaud P; Semakafu AM; Kumaranayake L; Gavyole A; Mabey D; Hayes R
Trop Med Int Health; 2005 Sep; 10(9):934-43. PubMed ID: 16135202
[TBL] [Abstract][Full Text] [Related]
13. HIV counselling and testing of pregnant women attending antenatal clinics in Botswana, 2001.
Rakgoasi SD
J Health Popul Nutr; 2005 Mar; 23(1):58-65. PubMed ID: 15884753
[TBL] [Abstract][Full Text] [Related]
14. Who should be screened for HIV infection? A cost-effectiveness analysis.
McCarthy BD; Wong JB; Muñoz A; Sonnenberg FA
Arch Intern Med; 1993 May; 153(9):1107-16. PubMed ID: 8481077
[TBL] [Abstract][Full Text] [Related]
15. The cost-effectiveness of prenatal carrier screening for cystic fibrosis.
Lieu TA; Watson SE; Washington AE
Obstet Gynecol; 1994 Dec; 84(6):903-12. PubMed ID: 7970468
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of integrated routine offering of prenatal HIV and syphilis screening in China.
Owusu-Edusei K; Tao G; Gift TL; Wang A; Wang L; Tun Y; Wei X; Wang L; Fuller S; Kamb ML; Bulterys M
Sex Transm Dis; 2014 Feb; 41(2):103-10. PubMed ID: 24413489
[TBL] [Abstract][Full Text] [Related]
17. Implementing the universal routine-offer antenatal HIV screening programme in New Zealand: results from the first year.
Morgan J; Mills G
N Z Med J; 2007 Nov; 120(1265):U2798. PubMed ID: 18264178
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of universal compared with voluntary screening for human immunodeficiency virus among pregnant women in Chicago.
Immergluck LC; Cull WL; Schwartz A; Elstein AS
Pediatrics; 2000 Apr; 105(4):E54. PubMed ID: 10742375
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of antenatal screening for neonatal alloimmune thrombocytopenia.
Killie MK; Kjeldsen-Kragh J; Husebekk A; Skogen B; Olsen JA; Kristiansen IS
BJOG; 2007 May; 114(5):588-95. PubMed ID: 17355359
[TBL] [Abstract][Full Text] [Related]
20. Breast cancer screening policies in developing countries: a cost-effectiveness analysis for India.
Okonkwo QL; Draisma G; der Kinderen A; Brown ML; de Koning HJ
J Natl Cancer Inst; 2008 Sep; 100(18):1290-300. PubMed ID: 18780864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
